DNA Damage Response in Alzheimer's Disease

DNA Damage Response in Alzheimer's Disease

DNA damage accumulates in neurons during aging and accelerates in Alzheimer's disease, contributing to transcriptional dysregulation, cellular senescence, and neuronal death. The DNA damage response (DDR) pathway is critically implicated in AD pathogenesis.

Sources of DNA Damage in AD

Endogenous Sources

• Reactive oxygen species: Mitochondrial dysfunction leads to oxidative DNA damage
• Replication stress: Neuronal cell cycle re-entry attempts
• Base excision repair errors: Accumulated 8-oxoguanine
• Telomere dysfunction: Accelerated aging phenotype

Exogenous Contributors

• Metal ion accumulation: Iron, copper promote DNA oxidation
• Environmental toxins: Pesticides, pollutants
• UV radiation: Cumulative exposure

DNA Lesion Types

| Lesion Type | Prevalence in AD | Detection Method |
|-------------|------------------|------------------|
| 8-oxoguanine | ↑↑↑ | Immunohistochemistry |
| DNA strand breaks | ↑↑ | TUNEL assay |
| DNA base alkylation | ↑ | Mass spectrometry |
| DNA crosslinks | ↑ | Comet assay |
| Telomere shortening | ↑↑ | qPCR |

Signaling Pathways

...

DNA Damage Response in Alzheimer's Disease

DNA damage accumulates in neurons during aging and accelerates in Alzheimer's disease, contributing to transcriptional dysregulation, cellular senescence, and neuronal death. The DNA damage response (DDR) pathway is critically implicated in AD pathogenesis.

Sources of DNA Damage in AD

Endogenous Sources

• Reactive oxygen species: Mitochondrial dysfunction leads to oxidative DNA damage
• Replication stress: Neuronal cell cycle re-entry attempts
• Base excision repair errors: Accumulated 8-oxoguanine
• Telomere dysfunction: Accelerated aging phenotype

Exogenous Contributors

• Metal ion accumulation: Iron, copper promote DNA oxidation
• Environmental toxins: Pesticides, pollutants
• UV radiation: Cumulative exposure

DNA Lesion Types

| Lesion Type | Prevalence in AD | Detection Method |
|-------------|------------------|------------------|
| 8-oxoguanine | ↑↑↑ | Immunohistochemistry |
| DNA strand breaks | ↑↑ | TUNEL assay |
| DNA base alkylation | ↑ | Mass spectrometry |
| DNA crosslinks | ↑ | Comet assay |
| Telomere shortening | ↑↑ | qPCR |

Signaling Pathways

Key DDR Components in AD

ATM/ATR Kinases

• ATM levels increase in AD brains
• Persistent activation indicates unrepaired damage
• Correlates with cognitive decline

p53 Pathway

• Hyperacetylated in AD neurons
• Promotes pro-apoptotic gene expression
• Contributes to neuronal vulnerability

PARP Hyperactivation

• Excessive PARP consumes NAD+
• Implicates energy crisis
• Leads to AIF-mediated cell death

Neuronal Consequences

Transcriptional Dysregulation

• Impaired activity-dependent gene expression
• Reduced synaptic plasticity genes
• Altered neuronal identity genes

Epigenetic Alterations

• DNA methyltransferase dysregulation
• Histone modifications from damage signaling
• Chromatin remodeling defects

Cellular Senescence

• DDR triggers senescent phenotype
• SASP propagates inflammation
• Contributes to "inflammaging"

Therapeutic Approaches

DNA Repair Enhancement

• Poly(ADP-ribose) polymerase inhibitors: Prevent energy depletion
• DNA repair enzyme activators: OGG1, Polβ enhancement
• NAD+ precursors: Support repair processes

Antioxidant Strategies

• Mitochondrial-targeted antioxidants
• ROS scavengers for oxidative damage

Senolytic Approaches

• Remove DNA damage-induced senescent neurons
• Clear SASP-producing cells

DNA Repair Pathways in Detail

Base Excision Repair (BER)

The primary pathway for repairing oxidative DNA damage:

DNA glycosylases: OGG1, NTH1 recognize damaged bases

AP endonuclease (APE1): Cleaves abasic sites

DNA polymerase β: Fill in single-nucleotide gaps

DNA ligase III: Seal nicks

In AD, BER is compromised due to:

• OGG1 dysfunction leading to 8-oxoguanine accumulation
• Polymerase β deficiency reducing repair capacity
• APE1 reduction impairing abasic site processing

Nucleotide Excision Repair (NER)

Handles bulky DNA adducts and UV-induced damage:

• Global genome NER (GG-NER): Surveys entire genome
• Transcription-coupled NER (TC-NER): Active genes

AD-specific alterations:

• XPC and XPA protein levels reduced
• Impaired repair of oxidative lesions
• Xeroderma pigmentosum group D (XPD) dysfunction

Mitochondrial DNA Repair

Mitochondria maintain limited DNA repair capacity:

• Mismatch repair: MSH3, MSH2 complexes
• Base excision repair: Full pathway present
• Direct reversal: O6-methylguanine DNA methyltransferase (MGMT)

Deficits in mitochondrial DNA repair contribute to mtDNA mutation accumulation in AD neurons.

DNA Damage Sensing Kinases

ATM (Ataxia-Telangiectasia Mutated)

The primary sensor for double-strand breaks:

• Activation: DNA ends trigger autophosphorylation
• Substrates: Chk2, p53, BRCA1, NBS1
• Function: Cell cycle arrest, repair, apoptosis

In AD:

• ATM levels elevated in vulnerable neurons
• Persistent activation indicates unrepaired damage
• Correlates with cognitive decline severity

ATR (ATM and Rad3-Related)

Responds to replication stress:

• Activation: RPA-coated single-stranded DNA
• Substrates: Chk1, RPA, RAD17
• Function: S-phase checkpoint, fork stability

AD-specific observations:

• ATR activation in neurons with cell cycle re-entry
• Contributes to replication stress response
• Links to p53-mediated apoptosis

Epigenetic Consequences

DNA Methylation Changes

DNA damage affects epigenetic regulation:

• DNMT1 dysfunction: Maintenance methyltransferase impaired
• 5-mC levels altered: Global hypomethylation in AD
• Gene-specific changes: Promoter hypermethylation of repair genes

Histone Modifications

Damage signaling alters chromatin:

• H2AX phosphorylation (γH2AX): DNA damage marker
• H3K9me3 changes: Heterochromatin maintenance
• H4K16ac reduction: Chromatin decompaction

Chromatin Remodeling

ATP-dependent chromatin remodelers:

• SWI/SNF complexes: Altered in AD
• CHD family: Expression changes
• HDAC activity: Generally increased

Neuronal Vulnerability

Why Neurons Are Susceptible

Post-mitotic neurons face unique challenges:

• Limited repair capacity: Reduced DNA repair enzyme expression
• High metabolic demand: Elevated ROS production
• Long lifespan: Cumulative damage accumulation
• Excitable activity: Increased oxidative stress

Cell Cycle Re-Entry

A pathological response to DNA damage:

• Cyclin expression: Aberrant cell cycle markers
• Phospho-Rb: Inactive state changes
• Proliferation signals: Failed S-phase completion
• Apoptotic outcome: Neuronal death

Biomarkers and Detection

DNA Damage Markers

| Marker | Detection Method | AD Relevance |
|--------|-------------------|---------------|
| 8-oxoguanine | Immunohistochemistry | Elevated in neurons |
| γH2AX | Western blot | Correlates with severity |
| TUNEL | Histochemistry | Apoptotic DNA breaks |
| Comet assay | Electrophoresis | Single-cell damage |

Repair Capacity Tests

• Comet assay: Measure repair efficiency
• Host cell reactivation: Reporter plasmid repair
• Chromosomal aberrations: Micronucleus formation

Therapeutic Strategies in Development

Small Molecule Enhancers

| Compound | Target | Development Stage |
|----------|--------|-------------------|
| PBM-16 | PARP1 inhibitor | Preclinical |
| OGG1 activator | Base excision repair | Discovery |
| NAD+ boosters | Poly(ADP-ribosyl)ation | Phase 2 |
| p53 modulators | Apoptosis prevention | Preclinical |

Gene Therapy Approaches

• OGG1 delivery: Restore glycosylase function
• APE1 delivery: Enhance endonuclease activity
• POLB delivery: Restore polymerase function

Combination Strategies

Synergistic approaches under investigation:

PARPi + antioxidants: Energy support + repair

Senolytic + immunomodulation: Clear damage + reduce inflammation

DNA repair + neurotrophic: Protect and repair

Cross-Links

• [Epigenetics in AD](/mechanisms/epigenetics-ad)
• [Cellular Senescence in AD](/mechanisms/cellular-senescence-alzheimers)
• [Mitochondrial Dysfunction in AD](/mechanisms/mitochondrial-dysfunction-ad)
• [Oxidative Stress in AD](/mechanisms/oxidative-stress-pathway)
• [cGAS-STING Pathway in AD](/mechanisms/cgas-sting-ad-pathway)
• [PARP and NAD+ Metabolism](/mechanisms/nad-metabolism-neurodegeneration)
• [p53 in Neurodegeneration](/mechanisms/p53-neurodegeneration)
• [Telomere Biology in Aging](/mechanisms/telomere-aging-neurodegeneration)

Animal Models

Base Excision Repair (BER)

The base excision repair pathway is the primary mechanism for repairing small, non-bulky DNA lesions, including oxidative damage such as 8-oxoguanine[fischer2014 2014, Fischer F, et al. OGG1 activity in AD. Free Radic Biol Med. 2014](https://pubmed.ncbi.nlm.nih.gov/24704567/)[silva2018 2018, Silva AR, et al. DNA base excision repair in AD. Neuroscience. 2018](https://pubmed.ncbi.nlm.nih.gov/29555315/). In AD, BER efficiency declines due to multiple factors:

• OGG1 dysfunction: 8-oxoguanine DNA glycosylase (OGG1) shows reduced activity in AD neurons, leading to accumulation of mutagenic 8-oxoguanine lesions
• Polβ deficiency: DNA polymerase β, the central enzyme in BER, is downregulated in AD brain[polL2009 2009, Pol L, et al. DNA polymerase beta deficiency in AD. J Neurochem. 2009](https://pubmed.ncbi.nlm.nih.gov/19166508/)
• XRCC1 mutations: XRCC1 scaffold protein variants are associated with increased AD risk

The BER pathway involves multiple sequential steps: lesion recognition by DNA glycosylases (OGG1, NTHL1, NEIL1/2), base removal creating an abasic site, AP endonuclease (APE1) cleavage, DNA polymerase β gap-filling, and DNA ligase III sealing. Each step is compromised in AD.

Nucleotide Excision Repair (NER)

NER removes bulky DNA adducts and helix-distorting lesions. While less studied in AD than BER, emerging evidence suggests NER dysfunction:

• XPA deficiency: XPA protein, essential for NER assembly, shows altered expression in AD
• Cockayne syndrome proteins: CSB and CSA, involved in transcription-coupled NER, are dysregulated
• UV-induced lesions: Accumulation of pyrimidine dimers in AD brain suggests NER impairment

Mitochondrial DNA Repair

Mitochondrial DNA (mtDNA) is particularly vulnerable to oxidative damage due to proximity to reactive oxygen species generation. The mitochondrial base excision repair (mtBER) pathway is critical:

• mtDNA mutations: Accumulation of point mutations and deletions in AD brain
• TET enzymes: 5-methylcytosine oxidation to 5-hydroxymethylcytosine is altered in AD mitochondria
• POLG mutations: DNA polymerase γ variants accelerate mtDNA damage accumulation

Homologous Recombination (HR) and Non-Homologous End Joining (NHEJ)

Double-strand breaks (DSBs) are the most cytotoxic DNA lesions. Two major repair pathways exist:

Homologous Recombination (HR):

• Uses sister chromatid as template
• Active in S/G2 phases
• Requires BRCA1, BRCA2, RAD51
• Declines with age and in AD

Non-Homologous End Joining (NHEJ):

• Direct ligation of broken ends
• Active throughout cell cycle
• Requires Ku70/Ku80, DNA-PKcs, Ligase IV
• Error-prone but essential in post-mitotic neurons

In AD, both pathways show dysfunction: HR components (BRCA1, RAD51) are downregulated, while NHEJ becomes predominant but with increased error rates.

DNA Damage and Synaptic Dysfunction

The DNA damage response directly impacts synaptic function through multiple mechanisms:

Activity-Dependent Gene Expression Impairment

Neuronal activity requires rapid transcriptional responses:

• Immediate early genes (IEGs): c-Fos, Arc, Egr1
• Synaptic plasticity genes: Synapsin, PSD-95, NMDA/AMPA receptor subunits
• DNA damage disrupts activity-dependent transcription by:
• p53-mediated repression of plasticity genes
• Chromatin condensation at neuronal enhancers
• ATM/ATR diversion from synaptic signaling

Synaptic Protein Synthesis

Local translation at synapses requires intact DNA:

• DNA damage reduces global translation via eIF2α phosphorylation
• Specific deficits in synaptic protein mRNAs
• Ribosome stalling at damaged DNA templates

Calcium Signaling Disruption

DNA damage affects calcium homeostasis:

• p53 can modulate calcium channels (L-type, NMDA)
• PARP activation depletes NAD+, affecting SIRT1 activity
• Mitochondrial DNA damage impairs calcium buffering

Epigenetic Consequences of DNA Damage

DNA damage and repair have profound epigenetic effects in AD:

DNA Methylation Alterations

• DNMT1 downregulation: Decreased maintenance methyltransferase
• Global hypomethylation: Especially in repetitive elements
• Gene-specific hypermethylation: At synaptic plasticity genes
• 5hmC accumulation: 5-hydroxymethylcytosine as epigenetic "scar"

Histone Modifications

• H2AX phosphorylation: γH2AX spreads beyond damage sites
• H3K9me3 changes: Heterochromatin redistribution
• H4K16ac reduction: Associated with transcriptional dysfunction
• Poly(ADP-ribosyl)ation: PARylated histones alter chromatin structure

Chromatin Remodeling

• SWI/SNF dysfunction: Altered nucleosome positioning
• CTA/NCT complex changes: Transcriptional repression
• Lamina remodeling: Nuclear scaffold alterations

Clinical Biomarkers and Diagnostics

DNA damage biomarkers are being explored for AD diagnosis:

Peripheral Biomarkers

• 8-oxodG in urine: Oxidative DNA damage marker
• γH2AX in lymphocytes: DSB marker
• Telomere length: Leukocyte telomere shortening correlates with AD

Neuroimaging

• PET with DNA damage probes: [^11C]Poly(ADP-ribose) PET
• Magnetic resonance spectroscopy: N-acetylaspartate decline

Cerebrospinal Fluid

• 8-oxodG in CSF: Neuronal DNA damage indicator
• Ape1 activity: BER efficiency marker
• TDP-43 fragments: Associated with DNA damage

Therapeutic Strategies and Clinical Trials

DNA Repair Enhancement

PARP Inhibitors:

• Olaparib (Lynparza): FDA-approved for cancer, being repurposed for AD
• Rucaparib: Shows neuroprotective effects in preclinical models
• Niraparib: Being investigated in phase II trials
• Mechanism: Prevents excessive PARP activation, conserves NAD+ pools

NAD+ Precursors:

• Nicotinamide riboside (NR): Phase III trial for MCI/AD (NCT03065543)
• Nicotinamide mononucleotide (NMN): Preclinical promise, human trials ongoing
• Mechanism: Supports PARP activity, SIRT1 function, mitochondrial health

DNA Repair Enzyme Activators:

• OGG1 agonists: Under development
• Polβ enhancers: Peptide-based approaches
• APE1 modulators: Protect against Aβ toxicity

Antioxidant Strategies

Mitochondrial-Targeted Antioxidants:

• MitoQ: CoQ10 attached to triphenylphosphonium
• MitoPBN: PBN derivatives
• SkQ1: Visual system-specific

ROS Scavengers:

• Edaravone: FDA-approved for ALS, investigated for AD
• Tempol: Superoxide dismutase mimetic

Senolytic Approaches

• ABT-263 (Navitoclax): BCL-xL inhibitor, depletes senescent cells
• Dasatinib + Quercetin: Combination senolytic
• Fisetin: Natural senolytic flavonoid

Clinical Trials (2024)

| Trial | Agent | Phase | Status | Outcome |
|-------|-------|-------|--------|---------|
| NCT03065543 | Nicotinamide riboside | III | Recruiting | Cognitive endpoints |
| NCT04040634 | PARP inhibitor | II | Completed | Biomarker changes |
| NCT04760067 | Mitochondrial antioxidant | II | Ongoing | Safety/efficacy |
| NCT05395451 | Senolytic combination | I/II | Recruiting | Safety profile |

Research Frontiers (2024-2025)

Single-Cell Insights

• Spatial genomics: DNA damage heterogeneity across brain cell types
• Neuron-specific DDR: Post-mitotic neurons show unique repair mechanisms
• Glial DNA damage: Microglia and astrocytes contribute to inflammatory DDR

Mechanistic Advances

• p53 isoforms: Δ133p53 and Δ40p53 have distinct neuronal roles
• Non-canonical DDR: DNA damage response outside classical kinases
• Cytoplasmic DNA sensing: cGAS-STING crosstalk with nuclear DDR

Therapeutic Innovation

• Gene therapy: AAV-delivered DNA repair enzymes
• CRISPR-based correction: Base editing of risk variants
• Epigenetic drugs: HDAC inhibitors to enhance DNA repair gene expression
• Combination therapy: PARP inhibitors + NAD+ precursors + senolytics

References

[Thadathil et al., DNA damage and repair in aging and AD (2022)](https://doi.org/10.1016/j.arr.2022.101676)

[Mastroeni et al., DNA methylation in aging and AD (2018)](https://doi.org/10.1111/acel.12798)

[Coppede et al., DNA repair in AD: A network approach (2015)](https://doi.org/10.1007/s12035-015-9506-6)

[Mehr et al., DNA damage and repair in AD (2020)](https://doi.org/10.3233/JAD-190929)

[Sharma et al., DNA repair therapeutics for neurodegeneration (2024)](https://doi.org/10.1038/s41583-024-00787-4)

Pathway Diagram

The following diagram shows the key molecular relationships involving DNA Damage Response in Alzheimer's Disease discovered through SciDEX knowledge graph analysis: